Plasma Neuronal and Glial Markers and Anterior Cingulate Metabolite Levels in Major Depressive Disorder: A Pilot Study
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Introduction: Neuroglial functions may be deteriorated in major depressive disorder (MDD). Objective: To evaluate the markers of glial and neuronal cell turnover and to explore their associations with brain metabolites. Methods: In 10 participants with MDD and 10 healthy controls (HC) we investigated neuronal and glial plasma markers (the neuron-specific enolase, NSE; and S100beta, S100B) and brain metabolites (N-acetyl aspartate, NAA; total choline, Cho; and total creatine, Cr). Blood was collected for NSE and S100B. NAA, Cho, and Cr metabolite levels were measured in the anterior cingulate cortex (ACC) with proton magnetic resonance spectroscopy (1 H-MRS) at 3T. Results: NSE and S100B levels were significantly higher in MDD subjects than in HC. The Cr level was significantly higher in MDD subjects than in HC, but the NAA and Cho levels did not differ between groups. NAA/Cr and Cho/Cr ratios were significantly lower in patients with MDD versus HC. S100B was negatively correlated with the Cho levels. Conclusions: These results provide supporting evidence of neuronal and glial distress in MDD. Neuronal viability appears decreased, whereas glial regenerative activity and energy metabolism in the ACC increase in acute major depressive episode. Since low concentrations of S100B have neuroplastic effects, these changes may indicate a possible compensatory mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“S100B levels are elevated in the CSF or serum of patients with MDD, 180”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [180]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The S100 family of EF-hand calcium-binding proteins: functions and pathology
SCHAFER, B. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)10020-7 · Cited by 999
The S100 protein family: History, function, and expression
Zimmer, D. B., Cornwall, E. H., Landar, A., & Song, W. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(95)00040-2 · Cited by 927
The S100 family of EF-hand calcium-binding proteins: functions and pathology
Schäfer, B. W., & Heizmann, C. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)80167-8 · Cited by 682
S100B in brain damage and neurodegeneration
Rothermundt, M., Peters, M., Prehn, J. H. M., & Arolt, V. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10303 · Cited by 609
A probability-based measure of effect size: Robustness to base rates and other factors.
Ruscio, J. (2008) · Psychological Methods · doi:10.1037/1082-989x.13.1.19 · Cited by 398
Evidence for a wide extra-astrocytic distribution of S100B in human brain
Steiner, J., Bernstein, H.-G., Bielau, H., Berndt, A., Brisch, R., Mawrin, C., Keilhoff, G., & Bogerts, B. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-2 · Cited by 283
Haque, A., Polcyn, R., Matzelle, D., & Banik, N. L. (2018) · Brain Sciences · doi:10.3390/brainsci8020033 · Cited by 244
Luykx, J. J., Laban, K. G., van den Heuvel, M. P., Boks, M. P. M., Mandl, R. C. W., Kahn, R. S., & Bakker, S. C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.05.014 · Cited by 235
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“…in the dorsolateral prefrontal cortex (dlPFC) of patients with MDD. 179 S100B levels are elevated in the CSF or serum of patients with MDD, 180 which suggests that S100B is a potential diagnostic biomarker for depressive episodes associated with MDD. Communication between neurons and…”
BackgroundO'Leary, L. A., & Mechawar, N. (2021) · Glia · doi:10.1002/glia.23994 · Cited by 124
“…been consistently correlated with MDD as a state marker in unmedicated patients, and some studies have shown they correlate with symptom severity and their normalization is predictive of successful treatment response (Ambrée et al., 2016; Fang et al., 2016; Gulen et al., 2016; Güleş et al., 2020).”
ResultKantrowitz, J. T., Dong, Z., Milak, M. S., Rashid, R., Kegeles, L. S., Javitt, D. C., Lieberman, J. A., & John Mann, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01541-1 · Cited by 100
“While a few [66, 67] but not all [68] studies suggest that NAA altered in MDD, this limitation was minimized by the lack of between-group differences for NAA, and the confirmatory analysis using Cr as a reference.”
ResultEnergy metabolism in major depressive disorder: Recent advances from omics technologies and imaging
Gu, X., Ke, S., Wang, Q., Zhuang, T., Xia, C., Xu, Y., Yang, L., & Zhou, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111869 · Cited by 99
Steinacker, P., Al Shweiki, M. R., Oeckl, P., Graf, H., Ludolph, A. C., Schönfeldt-Lecuona, C., & Otto, M. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.012 · Cited by 84
Correlation between S100B and severity of depression in MDD: A meta-analysis
Tural, Ü., Irvin, M., & Iosifescu, D. V. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2013042 · Cited by 38
Self-citationJing, D., Hou, X., Guo, X., Zhao, X., Zhang, K., Zhang, J., Kan, C., Han, F., Liu, J., & Sun, X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01386-w · Cited by 30
Brief mindfulness training increased glutamate metabolism in the anterior cingulate cortex
Tang, Y., Askari, P., & Choi, C. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001527 · Cited by 28
Xie, X., Shi, Y., Ma, L., Yang, W., Pu, J., Shen, Y., Liu, Y., Zhang, H., Lv, F., & Hu, L. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.020 · Cited by 26
Peripheral S100B Protein Levels in Five Major Psychiatric Disorders: A Systematic Review
Kozlowski, T., Bargieł, W., Grabarczyk, M., & Skibińska, M. (2023) · Brain Sciences · doi:10.3390/brainsci13091334 · Cited by 26
Zhang, D., Ji, Y., Chen, X., Chen, R., Wei, Y., Peng, Q., Lin, J., Yin, J., He-zhan, L., Cui, L., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.844422 · Cited by 25
Gudmundson, A. T., Koo, A., Virovka, A., Amirault, A. L., Soo, M., Cho, J. H., Oeltzschner, G., Edden, R. A. E., & Stark, C. E. L. (2023) · Analytical Biochemistry · doi:10.1016/j.ab.2023.115227 · Cited by 24
Miao, H., Zhong, S., Liu, X., Lai, S., He, J., Zhu, Y., Song, Z., Chen, P., Wang, Y., & Jia, Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.103 · Cited by 21
He, J., Wang, D., Ban, M., Kong, L., Xiao, Q., Yuan, F., & Zhu, X. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.001 · Cited by 19
Interferon-β Activity Is Affected by S100B Protein
Kazakov, A. S., Sofin, A. D., Avkhacheva, N. V., Deryusheva, E. I., Rastrygina, V. A., Permyakova, M. E., Uversky, V. N., Permyakov, E. A., & Permyakov, S. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041997 · Cited by 15
GFAP and Neuron Specific Enolase (NSE) in the Serum of Suicide Attempters
Bagheri, M., Ghaneialvar, H., Oshnokhah, M., & Salari, S. (2022) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.36.103 · Cited by 15
Zhong, Q., Lai, S., He, J., Zhong, S., Song, X., Wang, Y., Zhang, Y., Chen, G., Yan, S., & Jia, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.039 · Cited by 15
Lü, X., Lai, S., Luo, A., Huang, X., Wang, Y., Zhang, Y., He, J., Chen, G., Zhong, S., & Jia, Y. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.132 · Cited by 14
Testosterone synthesis was inhibited in the testis metabolomics of a depression mouse model
Chen, G., Zhang, W., Li, D., Song, J., & Dong, M.-X. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.143 · Cited by 10
He, P., Lu, X., Zhong, M., Weng, H., Wang, J., Zhang, X., Jiang, C., Geng, F., Shi, Y., & Zhang, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1449202 · Cited by 8
Peripheral Markers of Nervous Tissue Damage in Addictive and Affective Disorders
Levchuk, L. A., Рощина, О. В., Simutkin, G. G., Bokhan, N. A., & Ivanova, S. А. (2021) · Neurochemical Journal · doi:10.1134/s1819712421010074 · Cited by 6
Jeon, S. Y., Yang, H. W., Son, B. R., Baek, J., & Kim, J. L. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae235 · Cited by 6
Qiao, Y.-X., Dai, W., Yao, Y., Wei, Q.-Q., Yue, C.-X., Yin, Y., Li, Y.-F., & Zhang, L. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111698 · Cited by 4
Song, X., Yan, S., Lai, S., Zhang, Y., Wang, Y., He, J., Huang, D., Zhang, J., Lu, X., Chen, G., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06428-1 · Cited by 5
Neurospecific Proteins as Transdiagnostic Markers of Affective Disorders
Levchuk, L. A., Bokhan, N. A., & Ivanova, S. А. (2023) · Neurochemical Journal · doi:10.1134/s1819712423010117 · Cited by 4
Increased Serum S100β Concentration is Associated with Depression in Parkinson’s Disease
Jiang, G., Sheng, C., Yan, L., Wang, Z., Wang, Q., Chen, R., & Zhao, Y. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s423312 · Cited by 5
White, A. J., Robinson, J. L., Wilson, A. E., & Reid, M. A. (2026) · NeuroImage Clinical · doi:10.1016/j.nicl.2026.103959 · Cited by 3
Yin, L., Wang, F., Xia, K., Gao, R., Jiao, Y.-R., Fang, M., & Chen, C. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04007-6 · Cited by 3
Nomogram combined neuron-specific enolase and NIHSS for prediction of post stroke depression
Yan, C., Zheng, W., Si, T., Huang, L., Wen, L., Shen, H., & Qu, M. (2025) · International Journal of Neuroscience · doi:10.1080/00207454.2025.2488758 · Cited by 3
Neurospecific Proteins as Transdiagnostic Markers of Affective Disorders
Levchuk, L. A., Bokhan, N. A., & Ivanova, S. А. (2023) · Нейрохимия · doi:10.31857/s1027813323010119 · Cited by 2
Xia, J., Wu, X., Wang, Z., Zhang, L., Xu, P., Zhao, P., Liu, P., Shao, Y., Zhang, X., Lu, Y., et al. (2026) · Integrative Medicine Research · doi:10.1016/j.imr.2026.101289 · Cited by 1
Rawat, V., Upadhyay, D., Hans, G., Pandey, S., Sharan, P., & Sharma, U. (2026) · NMR in Biomedicine · doi:10.1002/nbm.70261 · Cited by 1
“Similarly, Güleş et al. [30] reported higher Cr levels in the ACC of patients with MDD compared to HCs.”
Levchuk, L. A., Рощина, О. В., Simutkin, G. G., Boiko, A. S., Kisel, N. I., Bokhan, N. A., & Ivanova, S. А. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.10.015
Roschina, O. V., Levchuk, L. A., Simutkin, G. G., Ivanova, S. А., & Bokhan, N. A. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-4-42-48
Niu, J., Xia, J., & Wei, L. (2025) · International Conference on Graphics and Image Processing (ICGIP) · doi:10.1117/12.3057810
“Moreover, the activity of neurons in the cingulate cortex decreased was significantly reduced during depressive episodes [32].”
Role of astrocytes in the development and progression of major depressive disorder
Jing, P., Sun, C., Xiao-peng, Y. I. N., Liu, X.-C., Tian, Q., & (673328), X.-B. Z. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.v16.i5.115794
Total N-acetylaspartate: A potential early biomarker of depression?
Hudhud, L., Haney, M., Petrović, P., Stiernman, L. J., & Lindgren, L. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121896
Blood ATX(N) Biomarkers and Cognitive Dysfunction in Severe Mental Illnesses
Crescenti, D., Petracci, I., Cesareni, A., Binetti, G. G., Borroni, B., & Ghidoni, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104260
Liu, Y., Zhong, Q., Peng, L., Wang, Y., Zhang, Y. S., Huang, D., Chen, P., Wu, Y., Lai, S., & Jia, Y. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122250
Ge, Q., Li, Y., Sun, T., Tan, Y., Wu, X., Wu, C., Zou, J., Yang, L., Zhang, J., & Gao, J. (2026) · Depression and Anxiety · doi:10.1155/da/7759663
Song, X., Huang, D., Liu, S., Ye, X., Zhong, Q., Wang, Y., Lai, S., Zhong, S., & Jia, Y. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122332
Malau, I. A., Wu, S., Chang, J. P., Chang, C., Chang, C.-H., Tsai, M., Chiang, Y., & Su, K. (2026) · Biomedicine · doi:10.37796/2211-8039.1712
Rahimova, R. R., & Aghayeva, A. R. (2026) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2026.5.346097
Yan, Q., Lai, H., Zhang, R., Ai, Q., Yang, Y., Wang, H., Wang, Z., & Chen, N. (2026) · Translational research · doi:10.1016/j.trsl.2026.11.002
Metadata
- Authors
- Güleş, E., Iosifescu, D. V., & Tural, Ü.
- Affiliations
- Kocaeli Üniversitesi (TR)
- Nathan Kline Institute for Psychiatric Research (US)
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 2020
- Volume
- 79
- Issue
- 3
- Pages
- 214-221
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W3005586777
- Cited by
- 42
- References
- 53
- Citations by year
- 2026: 11 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 5 · 2021: 8 · 2020: 1
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuropsychobiology (publishedVersion)
- PubMed (publishedVersion)
- Kocaeli Üniversitesi - AVESİS (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, plasma biomarkers, neuron-specific enolase, S100B, glial activity, anterior cingulate cortex, brain metabolites, N-acetylaspartate, choline, creatine, 1H NMR, neuroplasticity, neuronal viability, energy metabolism
- MeSH terms
- Adult, Aspartic Acid, Choline, Creatine, Major Depressive Disorder, Depressive Disorder, Major, Female, Gyrus Cinguli, Humans, Male, Middle Aged, Phosphopyruvate Hydratase, Pilot Projects, S100 Calcium Binding Protein beta Subunit, Proton Magnetic Resonance Spectroscopy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.